MedPath
HSA Approval

LINEZAN SOLUTION FOR INFUSION 2MG/ML

SIN16950P

LINEZAN SOLUTION FOR INFUSION 2MG/ML

LINEZAN SOLUTION FOR INFUSION 2MG/ML

February 16, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J01XX08

linezolid

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Anfarm Hellas S.A.

Active Ingredients

Linezolid

2 mg/ml

Linezolid

Documents

Package Inserts

Linezan Solution for Infusion PI.pdf

Approved: February 16, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LINEZAN SOLUTION FOR INFUSION 2MG/ML - HSA Approval | MedPath